SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Repeated open-market purchases by CEO Troy Wilson, including another 100,000-share buy, are driving attention and are being viewed by traders as a strong management-confidence signal. The community is broadly bullish and discussing short covering, a potential Kyowa Kirin acquisition, and KOMZIFTIs launch momentum, though some remain cautious about valuation and biotech execution risk.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The tokens steep post-launch decline has driven a dominant debate over whether it was a pump-and-dump tied to the Trump familys crypto ventures, with many traders citing heavy losses, weak utility, and possible insider selling. A small minority remains bullish on a speculative rebound or short squeeze, but the overall conversation is strongly bearish.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canada is drawing attention after monetizing a minority stake in Aeroplan, which traders view as validating the loyalty programs value and supporting debt repayment and share buybacks, alongside strong quarterly results and resilient travel demand. Bulls see the transaction and analyst upgrades as value-unlocking catalysts, while skeptics remain focused on fuel costs, labor expenses, leverage, and the companys reported loss.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

The stock is trending due to heavy community debate over the post-earnings $300M ATM equity offering, which is seen as a bearish overhang driving technical breakdown talk and gap-fill speculation. Despite strong fundamental results and institutional accumulation, the sentiment is dominated by dilution fears and short-term bearish chart patterns.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

Bearish natural-gas fundamentals are driving attention, with traders focused on above-average storage builds, elevated production, cooler weather risk and Freeport maintenance limiting LNG exports. Bulls are positioning for a heat-driven drawdown and short squeeze, while bears emphasize shoulder-season weakness, contango and BOILs leveraged decay.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

The Ninth Circuits ruling that sports-event contracts can be treated as gambling rather than federally regulated swaps is drawing attention as a potential regulatory win for DraftKings and a setback for Kalshi-style prediction markets. Traders are debating whether the decision will reduce competition and accelerate DraftKings Predictions growth, while others note the circuit split, possible Supreme Court review, and the stocks difficulty holding its initial gains.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Updated Phase III HARMONi overall-survival data for ivonescimab, showing more consistent benefit across Western and Asian patients, is driving attention ahead of the FDAs scheduled decision. Traders remain divided: bulls see improving evidence and insider buying as supportive of approval, while bears point to the earlier statistical OS miss, reliance on China-led data, and potential dilution or funding needs.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians CFO departure to GE Vernova, with an interim finance chief named during the R2 ramp, is driving the discussion and after-hours selling. Traders are divided between concerns about leadership and financing uncertainty and views that the move is overblown or could enable a stronger replacement, while R2 inventory, delivery execution, and profitability remain key underlying debates.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A bearish BMF short report criticizing SELLASs REGAL Phase 3 trial, historical controls, dilution and valuation drove the latest attention and selloff. Traders are divided between dismissing it as an unverified short-side thesis and worrying that the delayed 80th event and forthcoming topline data could point to unfavorable results.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Anticipation of Intellia completing its rolling BLA and receiving FDA acceptance for lonvo-z, following positive Phase 3 HAE data, is driving attention. Bulls view the potential first approved in-vivo CRISPR therapy and possible short covering as major catalysts, while skeptics cite cash burn, dilution, commercialization risk, and analyst concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AMZN  this is one of those slow grind ups that turns into something bigger

Cleobulus

StockTwits Web

Amazon.com Inc

  this is one of those slow grind ups that turns into something bigger